Literature DB >> 15047159

AH receptor antagonist inhibits constitutive CYP1A1 and CYP1B1 expression in rat BP8 cells.

Steven Roblin1, Allan B Okey, Patricia A Harper.   

Abstract

The BP8 variant of the 5L rat hepatoma cell line is completely devoid of aryl hydrocarbon receptor (AHR) and is a useful model to examine AHR function. Previous studies showed that BP8 cells, when transfected with mouse AHR, exhibit induction of a plasmid-based reporter even in the absence of exogenous ligands. We transfected BP8 cells with full-length human AHR and found that presence of the AHR alone was sufficient to induce substantial CYP1A1 and CYP1B1 mRNA without any exogenous AHR ligand. An AHR antagonist, 3,4-dimethoxyflavone, inhibited CYP1A1 and CYP1B1 expression in a dose-dependent manner. When we transfected BP8 cells with a mutated human AHR that is defective in ligand binding, expression of CYP1A1 and CYP1B1 was diminished but not abolished. Inhibition by the AHR antagonist along with the diminished response to the mutated AHR indicates that BP8 cells contain some agent that acts as an agonist ligand for the AHR.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15047159     DOI: 10.1016/j.bbrc.2004.03.016

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Crosstalk between the aryl hydrocarbon receptor and hypoxia on the constitutive expression of cytochrome P4501A1 mRNA.

Authors:  Nan Zhang; Mary K Walker
Journal:  Cardiovasc Toxicol       Date:  2007-10-30       Impact factor: 3.231

2.  Potential therapeutic significance of increased expression of aryl hydrocarbon receptor in human gastric cancer.

Authors:  Tie-Li Peng; Jie Chen; Wei Mao; Xin Liu; Yu Tao; Lian-Zhou Chen; Min-Hu Chen
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

3.  CYP1B1 as a therapeutic target in cardio-oncology.

Authors:  Alexa N Carrera; Marianne K O Grant; Beshay N Zordoky
Journal:  Clin Sci (Lond)       Date:  2020-11-13       Impact factor: 6.124

4.  The aryl hydrocarbon receptor activates ceramide biosynthesis in mice contributing to hepatic lipogenesis.

Authors:  Qing Liu; Limin Zhang; Erik L Allman; Troy D Hubbard; Iain A Murray; Fuhua Hao; Yuan Tian; Wei Gui; Robert G Nichols; Philip B Smith; Mallappa Anitha; Gary H Perdew; Andrew D Patterson
Journal:  Toxicology       Date:  2021-06-09       Impact factor: 4.571

5.  An Aryl Hydrocarbon Receptor-Mediated Amplification Loop That Enforces Cell Migration in ER-/PR-/Her2- Human Breast Cancer Cells.

Authors:  Olga Novikov; Zhongyan Wang; Elizabeth A Stanford; Ashley J Parks; Alejandra Ramirez-Cardenas; Esther Landesman; Israa Laklouk; Carmen Sarita-Reyes; Daniel Gusenleitner; Amy Li; Stefano Monti; Sara Manteiga; Kyongbum Lee; David H Sherr
Journal:  Mol Pharmacol       Date:  2016-08-29       Impact factor: 4.436

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.